Skip to main content
Erschienen in: Endocrine 2/2020

28.02.2020 | Original Article

Physiological factors contributing to HbA1c in the normal and pre-diabetic range: a cross-sectional analysis

verfasst von: Lea Bruhn, Dorte Vistisen, Camilla Trine Ravn Vainø, Leigh Perreault, Kristine Færch

Erschienen in: Endocrine | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Little is known about the underlying physiology that contributes to Haemoglobin A1c (HbA1c) in the normal and pre-diabetic range. We determined the contribution of fasting plasma glucose (FPG), 2-h plasma glucose (2hPG), insulin secretion, insulin sensitivity and endogenous glucose production to HbA1c levels in the normal and pre-diabetic range.

Methods

A total of 62 Danish men and women with normal or impaired glucose regulation were studied. HbA1c levels were measured and participants underwent an oral glucose tolerance test with measurements of FPG and 2hPG, an intravenous glucose tolerance test for determination of first-phase insulin release, and a hyperinsulinaemic euglycaemic clamp for estimation of peripheral and hepatic insulin sensitivity. Associations of HbA1c with the different measures of glucose metabolism were analysed by linear regression analysis.

Results

HbA1c levels ranged from 28 to 45 mmol/mol (4.7–6.3%) in the study population. 1 SD higher (log) FPG concentration (~1 mmol/L) was associated with 2 mmol/mol higher HbA1c concentration (P < 0.001). In comparison, 1 SD higher levels of (log) first-phase insulin secretion or (log) disposition index were associated with 1.5 mmol/mol lower HbA1c levels (P < 0.05). HbA1c was not associated with peripheral or hepatic insulin sensitivity, endogenous glucose production or 2hPG levels.

Conclusion

HbA1c levels within the normal and pre-diabetic range seem to reflect decreased insulin secretion to a higher extent than insulin resistance. Therefore, early prevention strategies for high-risk individuals identified by HbA1c are not straightforward. More research on how to improve the health of beta cells either directly or indirectly in high-risk individuals is needed.
Literatur
1.
Zurück zum Zitat S. Ligthart, T.T. van Herpt, M.J. Leening, M. Kavousi, A. Hofman, B.H. Stricker, M. van Hoek, E.J. Sijbrands, O.H. Franco, A. Dehghan, Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol. 4(1), 44–51 (2016)CrossRef S. Ligthart, T.T. van Herpt, M.J. Leening, M. Kavousi, A. Hofman, B.H. Stricker, M. van Hoek, E.J. Sijbrands, O.H. Franco, A. Dehghan, Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol. 4(1), 44–51 (2016)CrossRef
2.
Zurück zum Zitat E.S. Ford, G. Zhao, C. Li, Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J. Am. Coll. Cardiol. 55(13), 1310–1317 (2010)CrossRef E.S. Ford, G. Zhao, C. Li, Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J. Am. Coll. Cardiol. 55(13), 1310–1317 (2010)CrossRef
3.
Zurück zum Zitat J.M. Mooy, P.A. Grootenhuis, H. de Vries, P.J. Kostense, C. Popp-Snijders, L.M. Bouter, R.J. Heine, Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39(3), 298–305 (1996)CrossRef J.M. Mooy, P.A. Grootenhuis, H. de Vries, P.J. Kostense, C. Popp-Snijders, L.M. Bouter, R.J. Heine, Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39(3), 298–305 (1996)CrossRef
4.
Zurück zum Zitat K. Færch, K. Borch-Johnsen, J.J. Holst, A. Vaag, Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia 52(9), 1714–1723 (2009)CrossRef K. Færch, K. Borch-Johnsen, J.J. Holst, A. Vaag, Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia 52(9), 1714–1723 (2009)CrossRef
5.
Zurück zum Zitat American Diabetes Association, Standards of medical care in diabetes—2010. Diabetes Care 33(Suppl 1), S11–S61 (2010)CrossRef American Diabetes Association, Standards of medical care in diabetes—2010. Diabetes Care 33(Suppl 1), S11–S61 (2010)CrossRef
6.
Zurück zum Zitat The International Expert Committee, International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32(7), 1327–1334 (2009)CrossRef The International Expert Committee, International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32(7), 1327–1334 (2009)CrossRef
7.
Zurück zum Zitat I.M. Stratton, A.I. Adler, H.A. Neil, D.R. Matthews, S.E. Manley, C.A. Cull, D. Hadden, R.C. Turner, R.R. Holman, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321, 405–412 (2000) I.M. Stratton, A.I. Adler, H.A. Neil, D.R. Matthews, S.E. Manley, C.A. Cull, D. Hadden, R.C. Turner, R.R. Holman, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321, 405–412 (2000)
8.
Zurück zum Zitat T. Jørgensen, K. Borch-Johnsen, T.F. Thomsen, H. Ibsen, C. Glümer, P. Charlotta, A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur. J. Cardiovasc. Prev. Rehab. 10(5), 377–386 (2003)CrossRef T. Jørgensen, K. Borch-Johnsen, T.F. Thomsen, H. Ibsen, C. Glümer, P. Charlotta, A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur. J. Cardiovasc. Prev. Rehab. 10(5), 377–386 (2003)CrossRef
9.
Zurück zum Zitat K. Færch, A. Vaag, J. Holst, C. Glümer, O. Pedersen, K. Borch-Johnsen, Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 51(5), 853–861 (2008)CrossRef K. Færch, A. Vaag, J. Holst, C. Glümer, O. Pedersen, K. Borch-Johnsen, Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 51(5), 853–861 (2008)CrossRef
10.
Zurück zum Zitat R.A. DeFronzo, J.D. Tobin, R. Andres, Glucose clamp tecnique: a method for quantifying insulin secretion and resistance, Am. J. Physiol. 237(3), E214–E223 (1979) R.A. DeFronzo, J.D. Tobin, R. Andres, Glucose clamp tecnique: a method for quantifying insulin secretion and resistance, Am. J. Physiol. 237(3), E214–E223 (1979)
11.
Zurück zum Zitat K. Færch, C. Brøns, A.C. Alibegovic, A. Vaag, The disposition index: adjustment for peripheral vs. hepatic insulin sensitivity? J. Physiol. 588(5), 759–764 (2010)CrossRef K. Færch, C. Brøns, A.C. Alibegovic, A. Vaag, The disposition index: adjustment for peripheral vs. hepatic insulin sensitivity? J. Physiol. 588(5), 759–764 (2010)CrossRef
12.
Zurück zum Zitat R. Steele, Influences of glucose loading and of injected insulin on hepatic glucose output. Ann. N. Y. Acad. Sci. 82, 420–430 (1959)CrossRef R. Steele, Influences of glucose loading and of injected insulin on hepatic glucose output. Ann. N. Y. Acad. Sci. 82, 420–430 (1959)CrossRef
13.
Zurück zum Zitat M.A. Abdul-Ghani, M. Matsuda, B. Balas, R.A. DeFronzo, Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30(1), 89–94 (2007)CrossRef M.A. Abdul-Ghani, M. Matsuda, B. Balas, R.A. DeFronzo, Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30(1), 89–94 (2007)CrossRef
14.
Zurück zum Zitat M.J. Christopher, C. Rantzau, G.M. Ward, F.P. Alford, Insulinopenia and hyperglycemia influence the in vivo partitioning of GE and SI. Am. J. Physiol. 268(3 Pt 1), E410–E421 (1995)PubMed M.J. Christopher, C. Rantzau, G.M. Ward, F.P. Alford, Insulinopenia and hyperglycemia influence the in vivo partitioning of GE and SI. Am. J. Physiol. 268(3 Pt 1), E410–E421 (1995)PubMed
15.
Zurück zum Zitat O. Hother-Nielsen, H. Beck-Nielsen, On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia 33(10), 603–610 (1990)CrossRef O. Hother-Nielsen, H. Beck-Nielsen, On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia 33(10), 603–610 (1990)CrossRef
16.
Zurück zum Zitat R.A. DeFronzo, Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58(4), 773–795 (2009)CrossRef R.A. DeFronzo, Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58(4), 773–795 (2009)CrossRef
17.
Zurück zum Zitat E. Barry, S. Roberts, J. Oke, S. Vijayaraghavan, R. Normansell, T. Greenhalgh, Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions, BMJ 356, i6538 (2017) E. Barry, S. Roberts, J. Oke, S. Vijayaraghavan, R. Normansell, T. Greenhalgh, Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions, BMJ 356, i6538 (2017)
18.
Zurück zum Zitat L. Monnier, H. Lapinski, C. Colette, Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c. Diabetes Care 26(3), 881–885 (2003)CrossRef L. Monnier, H. Lapinski, C. Colette, Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c. Diabetes Care 26(3), 881–885 (2003)CrossRef
19.
Zurück zum Zitat M. Riddle, G. Umpierrez, A. DiGenio, R. Zhou, J. Rosenstock, Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes. Diabetes Care 34(12), 2508–2514 (2011)CrossRef M. Riddle, G. Umpierrez, A. DiGenio, R. Zhou, J. Rosenstock, Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes. Diabetes Care 34(12), 2508–2514 (2011)CrossRef
20.
Zurück zum Zitat K. Færch, M. Alssema, D.J. Mela, R. Borg, D. Vistisen, Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA1c in individuals with and without diabetes. Nutr. Diabetes 8(1), 38 (2018)CrossRef K. Færch, M. Alssema, D.J. Mela, R. Borg, D. Vistisen, Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA1c in individuals with and without diabetes. Nutr. Diabetes 8(1), 38 (2018)CrossRef
21.
Zurück zum Zitat C. Chen, Y.Q. Tu, P. Yang, Q.L. Yu, S. Zhang, F. Xiong, C.Y. Wang, Assessing the impact of cigarette smoking on beta-cell function and risk for type 2 diabetes in a non-diabetic Chinese cohort. Am. J. Transl. Res. 10(7), 2164–2174 (2018)PubMedPubMedCentral C. Chen, Y.Q. Tu, P. Yang, Q.L. Yu, S. Zhang, F. Xiong, C.Y. Wang, Assessing the impact of cigarette smoking on beta-cell function and risk for type 2 diabetes in a non-diabetic Chinese cohort. Am. J. Transl. Res. 10(7), 2164–2174 (2018)PubMedPubMedCentral
22.
Zurück zum Zitat T. Li, L. Ni, Z. Zhao, X. Liu, Z. Lai, X. Di, Z. Xie, X. Song, X. Wang, R. Zhang, C. Liu, Melatonin attenuates smoking-induced hyperglycemia via preserving insulin secretion and hepatic glycogen synthesis in rats. J. Pineal Res. 64(4), e12475 (2018)CrossRef T. Li, L. Ni, Z. Zhao, X. Liu, Z. Lai, X. Di, Z. Xie, X. Song, X. Wang, R. Zhang, C. Liu, Melatonin attenuates smoking-induced hyperglycemia via preserving insulin secretion and hepatic glycogen synthesis in rats. J. Pineal Res. 64(4), e12475 (2018)CrossRef
23.
Zurück zum Zitat K. Færch, A. Vaag, D.R. Witte, T. Jørgensen, O. Pedersen, K. Borch-Johnsen, Predictors of future fasting and 2-hour post-OGTT plasma glucose levels in middle-aged men and women—the Inter99 study. Diabet. Med. 26(4), 377–383 (2009)CrossRef K. Færch, A. Vaag, D.R. Witte, T. Jørgensen, O. Pedersen, K. Borch-Johnsen, Predictors of future fasting and 2-hour post-OGTT plasma glucose levels in middle-aged men and women—the Inter99 study. Diabet. Med. 26(4), 377–383 (2009)CrossRef
24.
Zurück zum Zitat A. Borai, C. Livingstone, F. Abdelaal, A. Bawazeer, V. Keti, G. Ferns, The relationship between glycosylated haemoglobin (HbA1c) and measures of insulin resistance across a range of glucose tolerance. Scand. J. Clin. Lab. Investig. 71(2), 168–172 (2011)CrossRef A. Borai, C. Livingstone, F. Abdelaal, A. Bawazeer, V. Keti, G. Ferns, The relationship between glycosylated haemoglobin (HbA1c) and measures of insulin resistance across a range of glucose tolerance. Scand. J. Clin. Lab. Investig. 71(2), 168–172 (2011)CrossRef
25.
Zurück zum Zitat Y. Heianza, Y. Arase, K. Fujihara, H. Tsuji, K. Saito, S.D. Hsieh, S. Kodama, H. Shimano, N. Yamada, S. Hara, H. Sone, High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8). Diabet. Med. J. Br. Diabet. Assoc. 29(10), 1285–1290 (2012)CrossRef Y. Heianza, Y. Arase, K. Fujihara, H. Tsuji, K. Saito, S.D. Hsieh, S. Kodama, H. Shimano, N. Yamada, S. Hara, H. Sone, High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8). Diabet. Med. J. Br. Diabet. Assoc. 29(10), 1285–1290 (2012)CrossRef
26.
Zurück zum Zitat M. Kanat, D. Winnier, L. Norton, N. Arar, C. Jenkinson, R.A. DeFronzo, M.A. Abdul-Ghani, The relationship between beta-cell function and glycated hemoglobin: results from the Veterans Administration Genetic Epidemiology Study. Diabetes Care 34(4), 1006–1010 (2011)CrossRef M. Kanat, D. Winnier, L. Norton, N. Arar, C. Jenkinson, R.A. DeFronzo, M.A. Abdul-Ghani, The relationship between beta-cell function and glycated hemoglobin: results from the Veterans Administration Genetic Epidemiology Study. Diabetes Care 34(4), 1006–1010 (2011)CrossRef
27.
Zurück zum Zitat K. Færch, N. Borup-Johansen, D.R. Witte, T. Lauritzen, M.E. Jørgensen, D. Vistisen, Relationship between insulin resistance and beta cell dysfunction in subphenotypes of pre-diabetes and type 2 diabetes. J. Clin. Endocrinol. Metab. 100(2), 707–716 (2015)CrossRef K. Færch, N. Borup-Johansen, D.R. Witte, T. Lauritzen, M.E. Jørgensen, D. Vistisen, Relationship between insulin resistance and beta cell dysfunction in subphenotypes of pre-diabetes and type 2 diabetes. J. Clin. Endocrinol. Metab. 100(2), 707–716 (2015)CrossRef
28.
Zurück zum Zitat M. Fizelova, A. Stancáková, C. Lorenzo, S.M. Haffner, H. Cederberg, J. Kuusisto, M. Laakso, Glycated hemoglobin levels are mostly dependent on nonglycemic parameters in 9398 Finnish men without diabetes. J. Clin. Endocrinol. Metab. 100(5), 1989–1996 (2015)CrossRef M. Fizelova, A. Stancáková, C. Lorenzo, S.M. Haffner, H. Cederberg, J. Kuusisto, M. Laakso, Glycated hemoglobin levels are mostly dependent on nonglycemic parameters in 9398 Finnish men without diabetes. J. Clin. Endocrinol. Metab. 100(5), 1989–1996 (2015)CrossRef
29.
Zurück zum Zitat K. Færch, A. Hulman, T.P. Solomon, Heterogeneity of pre-diabetes and type 2 diabetes: implications for prediction, prevention and treatment responsiveness. Curr. Diab Rev. 12(1), 30–41 (2015)CrossRef K. Færch, A. Hulman, T.P. Solomon, Heterogeneity of pre-diabetes and type 2 diabetes: implications for prediction, prevention and treatment responsiveness. Curr. Diab Rev. 12(1), 30–41 (2015)CrossRef
30.
Zurück zum Zitat W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, D.M. Nathan, P.P.R.G. Diabetes, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med 346(6), 393–403 (2002)CrossRef W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, D.M. Nathan, P.P.R.G. Diabetes, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med 346(6), 393–403 (2002)CrossRef
31.
Zurück zum Zitat T. Saito, M. Watanabe, J. Nishida, T. Izumi, M. Omura, T. Takagi, R. Fukunaga, Y. Bandai, N. Tajima, Y. Nakamura, M. Ito, Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch. Intern. Med. 171(15), 1352–1360 (2011)CrossRef T. Saito, M. Watanabe, J. Nishida, T. Izumi, M. Omura, T. Takagi, R. Fukunaga, Y. Bandai, N. Tajima, Y. Nakamura, M. Ito, Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch. Intern. Med. 171(15), 1352–1360 (2011)CrossRef
32.
Zurück zum Zitat RISE Consortium, Impact of insulin and metformin versus metformin alone on beta-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes. Diabetes Care 41(8), 1717–1725 (2018)CrossRef RISE Consortium, Impact of insulin and metformin versus metformin alone on beta-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes. Diabetes Care 41(8), 1717–1725 (2018)CrossRef
33.
Zurück zum Zitat RISE Consortium, Lack of durable improvements in beta-cell function following withdrawal of pharmacological interventions in adults with impaired glucose tolerance or recently diagnosed type 2 diabetes. Diabetes Care 42(9), 1742–1751 (2019)CrossRef RISE Consortium, Lack of durable improvements in beta-cell function following withdrawal of pharmacological interventions in adults with impaired glucose tolerance or recently diagnosed type 2 diabetes. Diabetes Care 42(9), 1742–1751 (2019)CrossRef
Metadaten
Titel
Physiological factors contributing to HbA1c in the normal and pre-diabetic range: a cross-sectional analysis
verfasst von
Lea Bruhn
Dorte Vistisen
Camilla Trine Ravn Vainø
Leigh Perreault
Kristine Færch
Publikationsdatum
28.02.2020
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02234-3

Weitere Artikel der Ausgabe 2/2020

Endocrine 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.